Stock Earnings

Question 1

What are Agios Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Agios Pharmaceuticals Inc has a total asset of $1,663, Net profit of $673

Question 2

What are the key financial ratios for AGIO?

Accepted Answer

Agios Pharmaceuticals Inc's Current ratio is 13.63, has a Net margin is 1,869.44, sales per share of $0.62.

Question 3

How is Agios Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

Agios Pharmaceuticals Inc largest revenue segment is Medicines for Cellular Metabolism, at a revenue of 36,498,000 in the most earnings release.For geography, United States is the primary market for Agios Pharmaceuticals Inc, at a revenue of 36,498,000.

Question 4

Is Agios Pharmaceuticals Inc profitable?

Accepted Answer

yes, according to the latest financial statements, Agios Pharmaceuticals Inc has a net profit of $673

Question 5

Does Agios Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, Agios Pharmaceuticals Inc has liability of 122

Question 6

How many outstanding shares for Agios Pharmaceuticals Inc?

Accepted Answer

Agios Pharmaceuticals Inc has a total outstanding shares of 57.15

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	44	36	26	14	0	0
Revenue Growth (YoY)	38%	38%	86%	--	--	--
Cost of Revenue	5	4	2	1	--	--
Gross Profit	39	32	23	12	--	--
Selling, General & Admin	180	156	119	121	121	115
Research & Development	334	301	295	279	256	220
Operating Expenses	514	458	415	401	378	335
Other Non Operating Income (Expenses)	3	6	6	6	14	0
Pretax Income	-410	717	-352	-231	-356	-329
Income Tax Expense	-8	44	--	--	--	--
Net Income	-401	673	-352	-231	1,604	-327
Net Income Growth	-160%	-291%	52%	-113.99%	-591%	-20%
Shares Outstanding (Diluted)	58.13	57.88	55.65	54.79	60.45	69
Shares Change (YoY)	-1%	4%	2%	-9%	-12%	15%
EPS (Diluted)	-6.9	11.63	-6.32	-4.23	26.54	-4.74
EPS Growth	-160%	-284%	50%	-115.99%	-660%	-31%
Free Cash Flow	-414	-391	-297	-314	-413	-305
Free Cash Flow Per Share	-7.12	-6.75	-5.33	-5.73	-6.83	-4.42
Gross Margin	88.63%	88.88%	88.46%	85.71%	--	--
Operating Margin	-1,079.54%	-1,180.55%	-1,503.84%	-2,778.57%	0%	0%
Profit Margin	-911.36%	1,869.44%	-1,353.84%	-1,650%	0%	0%
Free Cash Flow Margin	-940.9%	-1,086.11%	-1,142.3%	-2,242.85%	0%	0%
EBITDA	-470	-420	-385	-381	-369	-326
EBITDA Margin	-1,068.18%	-1,166.66%	-1,480.76%	-2,721.42%	0%	0%
D&A For EBITDA	5	5	6	8	9	9
EBIT	-475	-425	-391	-389	-378	-335
EBIT Margin	-1,079.54%	-1,180.55%	-1,503.84%	-2,778.57%	0%	0%
Effective Tax Rate	1.95%	6.13%	--	--	--	--

Agios Pharmaceuticals Inc (AGIO) Price

AGIO Stock Price Chart

AGIO Income

Follow-Up Questions